Developer of a synthetic virology platform designed to engineer oncolytic viral therapies for cancer treatment. The company's platform offers RNA-based viral therapies with selective infection, high l...

Healthcare
New York, NY, United States
Founded 2016
6 employees
Website
Valuation
$17M
Market implied
Share Price
N/A
Total Raised
$8.1M
Last Round
N/A

Get the full picture

Create a free account to unlock Humane Genomics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required